BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17634152)

  • 1. Developments in lupus 2006.
    Hansen A; Hiepe F; Dörner T
    Arthritis Res Ther; 2007; 9(4):215. PubMed ID: 17634152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the immunopathogenesis of systemic lupus erythematosus.
    Tsokos GC; Lo MS; Costa Reis P; Sullivan KE
    Nat Rev Rheumatol; 2016 Nov; 12(12):716-730. PubMed ID: 27872476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs.
    Lyn-Cook BD; Xie C; Oates J; Treadwell E; Word B; Hammons G; Wiley K
    Mol Immunol; 2014 Sep; 61(1):38-43. PubMed ID: 24865418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine models of systemic lupus erythematosus.
    Perry D; Sang A; Yin Y; Zheng YY; Morel L
    J Biomed Biotechnol; 2011; 2011():271694. PubMed ID: 21403825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapeutics for systemic lupus erythematosus.
    Wiesendanger M; Stanevsky A; Kovsky S; Diamond B
    Curr Opin Rheumatol; 2006 May; 18(3):227-35. PubMed ID: 16582684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of the treatment of systemic lupus erythematosus.
    Schattner A; Naparstek Y
    Clin Exp Rheumatol; 2005; 23(2):254-60. PubMed ID: 15895901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against complement components in systemic lupus erythematosus - role in the pathogenesis and clinical manifestations.
    Hristova MH; Stoyanova VS
    Lupus; 2017 Dec; 26(14):1550-1555. PubMed ID: 29092674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathology and the gene therapy of lupus.
    Mageed RA; Prud'homme GJ
    Gene Ther; 2003 May; 10(10):861-74. PubMed ID: 12732872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus.
    Li Q; Wu H; Liao W; Zhao M; Chan V; Li L; Zheng M; Chen G; Zhang J; Lau CS; Lu Q
    J Autoimmun; 2018 Sep; 93():1-15. PubMed ID: 30017673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of kidney disease in systemic lupus erythematosus.
    Bagavant H; Fu SM
    Curr Opin Rheumatol; 2009 Sep; 21(5):489-94. PubMed ID: 19584729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus erythematosus. Part I: epidemiology, genetics and immunology.
    Kunz M
    J Dtsch Dermatol Ges; 2013 Aug; 11(8):709-19; quiz 720, 709-720; quiz 721. PubMed ID: 23889785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.
    Barrat FJ; Meeker T; Chan JH; Guiducci C; Coffman RL
    Eur J Immunol; 2007 Dec; 37(12):3582-6. PubMed ID: 18034431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus.
    Richez C; Blanco P; Rifkin I; Moreau JF; Schaeverbeke T
    Joint Bone Spine; 2011 Mar; 78(2):124-30. PubMed ID: 20961794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.
    Zhuang H; Han S; Li Y; Kienhöfer D; Lee P; Shumyak S; Meyerholz R; Rosadzinski K; Rosner D; Chan A; Xu Y; Segal M; Sobel E; Yang LJ; Hoffmann MH; Reeves WH
    Arthritis Rheumatol; 2016 Dec; 68(12):2917-2928. PubMed ID: 27274010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in mechanisms of systemic lupus erythematosus.
    Dema B; Charles N
    Discov Med; 2014 May; 17(95):247-55. PubMed ID: 24882716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus trials: successes and issues.
    Ginzler EM; Moldovan I
    Curr Opin Rheumatol; 2004 Sep; 16(5):499-504. PubMed ID: 15314485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on pathogenesis of systemic lupus erythematosus.
    Ahmadpoor P; Dalili N; Rostami M
    Iran J Kidney Dis; 2014 May; 8(3):171-84. PubMed ID: 24878938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2015 Feb; 18(2):250-9. PubMed ID: 25639676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic basis for systemic lupus erythematosus.
    Perdriger A; Werner-Leyval S; Rollot-Elamrani K
    Joint Bone Spine; 2003 Mar; 70(2):103-8. PubMed ID: 12713853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on human systemic lupus erythematosus genetics.
    Tsao BP
    Curr Opin Rheumatol; 2004 Sep; 16(5):513-21. PubMed ID: 15314487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.